Pharma companies settle M&A dispute

Multinational pharmaceutical companies Teva and Allergan have agreed a US$700 million settlement of a dispute over the value of a generic drug business that Teva acquired in a US$40.5 billion deal.


Get unlimited access to all Global Arbitration Review content